About
Projects
Publications
Contact

Commentary

Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy

Feb 1, 2023

© 2025 Michael Heming. This work is licensed under CC BY NC ND 4.0

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.